Chris Rhoades, MD, Joins Mount Carmel Grove City Cancer Center as part of Affiliation with The James Cancer NetworkNovember 29, 2022
Categories: Mount Carmel News
Columbus, Ohio – Mount Carmel Health System welcomes Chris Rhoades, MD, to the Mount Carmel Grove City Cancer Center to provide medical oncology services to its patients. He is the first medical oncologist to join the Mount Carmel Grove City Cancer Center through its affiliation with The James Cancer Network at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), where he will continue to also serve as the director of James Cancer Network Clinical Operations and Community Engagement.
“We're proud to add Dr. Rhoades’ expertise to our team of cancer experts at Mount Carmel Grove City,” said Lorraine Lutton, president and CEO at Mount Carmel. "Having a medical oncologist affiliated with The James Cancer Network through our partnership brings access to additional research and treatment options, and expands our ability to provide high-quality, world-class cancer care to our patients in the Grove City area."
The Mount Carmel and The James Cancer Network affiliation strengthens Mount Carmel’s oncology program by offering medical and radiation oncology, along with other cancer services, under one roof, enhancing the continuum of care for patients within the health system.
“Dr. Rhoades provides another layer of medical oncology expertise to The James Cancer Network,” said David E. Cohn, MD, MBA, interim CEO of The James. “He will help the network’s leadership team enhance care coordination and clinical relationships among the OSUCCC – James and all of our network affiliates, including Mount Carmel Grove City, as we work together to provide outstanding cancer care to patients within their home communities.”
Prior to his current leadership role with the James Cancer Network at the OSUCCC – James, Dr. Rhoades served as medical director of outpatient clinical services for the OSUCCC – James. Before joining Ohio State, Dr. Rhoades was medical director of oncology at Mercy Health – St. Rita’s and practiced at Oncology Specialists of St. Rita’s in Lima, Ohio. He has served as a panel member of the National Comprehensive Cancer Network®, an alliance of leading cancer centers devoted to patient care, research, and education and remains an assistant clinical professor of internal medicine.
Dr. Rhoades graduated from the University of Toledo with a bachelor’s in biology and received his medical degree from The Ohio State University College of Medicine. His internship and residency in internal medicine, along with his fellowship in hematology and oncology, took place at The Ohio State University Wexner Medical Center.
Currently, Mount Carmel’s Cancer Center in Grove City offers diagnostic services and integrated, multidisciplinary care for all types of cancers, performing more than 35,000 outpatient treatments, 3,500 inpatient treatments and 2,600 cancer surgeries each year.
For more information on Mount Carmel Health System and The James Cancer Network, visit
About Mount Carmel Health System
Mount Carmel Health System, a member of Trinity Health, has provided high-quality, comprehensive healthcare services in central Ohio for more than 135 years. Our team of more than 8,600 colleagues, 1,970 physicians and 360 volunteers provides compassionate, people-centered primary and specialty care at its four hospitals—Mount Carmel East, Mount Carmel Grove City, Mount Carmel New Albany and Mount Carmel St. Ann’s, as well as Diley Ridge Medical Center, an affiliation of Mount Carmel and Fairfield Medical Center. The health system also includes Mount Carmel Medical Group and Mount Carmel Health Partners, along with surgery centers, emergency and ambulatory care centers, and hospice and home care services throughout the region.
About the OSUCCC – James
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 53 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs provided by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors and with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit www.cancer.osu.edu.